Faulty Syringes, Other Issues Lead to Warning Letter for Collagen Matrix

The GMP Letter
A A
Collagen Matrix has received a warning letter after the FDA found cGMP violations and quality system issues with its devices for use in oral/maxillofacial, neurosurgery and orthopedic-spine surgery.

To View This Article:

Login

Subscribe To The GMP Letter